Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Pashna N. Munshi"'
Autor:
Pashna N. Munshi, Jane Fall-Dickson, Joanne Assarsson, Samira Beheshtian, Tania Lobo, Anthony Chicaiza, Felice Yang, Michele L. Donato, Sukhdeep Kaur, Hyung Suh, Alene Mathurin, Shuqi Wang, Jaeil Ahn, Kristi Graves
Publikováno v:
Transplantation and Cellular Therapy. 29:S361-S362
Autor:
Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew L. Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph Rosenblatt, Jiali Yan, Qinghua Song, Weixin Peng, Christine Lui, Jacob Wulf, Rhine R. Shen, Soumya Poddar, Harry Miao, Sara Beygi, Caron A. Jacobson
Publikováno v:
Transplantation and Cellular Therapy. 29:S374
Autor:
Pashna N. Munshi, Yue Chen, Kwang W. Ahn, Farrukh T. Awan, Amanda Cashen, Geoffrey Shouse, Mazyar Shadman, Paul Shaughnessy, Joanna Zurko, Frederick L. Locke, Aaron M. Goodman, Jose C. Villaboas Bisneto, Craig Sauter, Mohamad A. Kharfan-Dabaja, Gabrielle Meyers, Samantha Jaglowski, Alex Herrera, Mehdi Hamadani
Publikováno v:
Transplantation and cellular therapy. 28(8)
Data for outcomes after autologous hematopoietic cell transplantation (auto-HCT) in diffuse large B-cell lymphoma (DLBCL) patients ≥70 years are limited. Auto-HCT is feasible in older DLBCL patients. Using the Center for International Blood and Mar
Autor:
Miguel Angel Diaz, David Szwajcer, Lynette C.Y. Chee, Claudio G. Brunstein, Mary Eapen, Nina Orfali, David A. Rizzieri, Timothy Prestidge, Ian K. McNiece, Olle Ringdén, Melhem Solh, Pashna N. Munshi, Michael R. Grunwald, Sachiko Seo, Hillard M. Lazarus, Muhammad Bilal Abid, Mei-Jie Zhang, Filippo Milano, Jean A. Yared, Peiman Hematti, Jaap Jan Boelens, Mariam Allbee-Johnson, Marcie L. Riches, Scott D. Solomon, Andrew S. Artz, Jingmei Hsu, Koen van Besien
Publikováno v:
Transplant Cell Ther
The in vivo depletion of recipient and donor T lymphocytes using antithymocyte globulin (ATG; Thymoglobulin) is widely adopted in allogeneic hematopoietic stem cell transplantation (HCT) to reduce the incidence of both graft failure and graft-versus-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac04ae666f791dd92ad2942b1a5b227
https://europepmc.org/articles/PMC8671234/
https://europepmc.org/articles/PMC8671234/
Autor:
Carmelo Carlo-Stella, Kami J. Maddocks, Sairah Ahmed, Manali Kamdar, Mazyar Shadman, Mahmoud Aljurf, Tycel Phillips, Brad S. Kahl, David J. Inwards, Martin Dreyling, Frederick L. Locke, Mohamed A. Kharfan-Dabaja, Nilanjan Ghosh, Amanda F. Cashen, Michael Wang, Jonathan W. Friedberg, Anna Sureda, Mats Jerkeman, Stephen P. Robinson, Matthew A. Lunning, Timothy S. Fenske, Jonathon B. Cohen, John P. Leonard, Craig S. Sauter, Alex F. Herrera, Pashna N. Munshi, Vaishalee P. Kenkre, Bipin N. Savani, Peter Dreger, Veronika Bachanova, Mehdi Hamadani, Ambuj Kumar, Sonali M. Smith, Brian T. Hill
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Transplantation and cellular therapy
Universidad de Barcelona
Transplantation and cellular therapy
Autologous (auto-) and allogeneic (allo-) hematopoietic cell transplantation (HCT) are accepted treatment modalities in contemporary treatment algorithms for mantle cell lymphoma (MCL). Chimeric antigen receptor (CAR) T cell therapy recently received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7add1b94fdc73da4cadeabe5841d900
http://hdl.handle.net/2445/180086
http://hdl.handle.net/2445/180086
Autor:
Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew L. Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph Rosenblatt, Marika Sherman, Jinghui Dong, Alessandro Giovanetti, Yin Yang, Christine Lui, Zahid Bashir, A. Scott Jung, Caron A. Jacobson
Publikováno v:
Transplantation and Cellular Therapy. 28:S64-S65
Autor:
Pashna N. Munshi, Jane Fall-Dickson, Joanne Assarsson, Samira Beheshtian, Tania Lobo, Anthony Chicaiza, Felice Yang, Michele L. Donato, Sukhdeep Kaur, Hyung Suh, Scott D. Rowley, Kristi Graves
Publikováno v:
Transplantation and Cellular Therapy. 28:S400-S401
Autor:
Jacqueline W. Mays, Sandra A. Mitchell, Filip Pirsl, Lindsay M. Morton, Claire L. Ruben, Galen O. Joe, Leora E. Comis, Jeannette Nashed, Seth M. Steinberg, Steven Z. Pavletic, Pashna N. Munshi, Alen Ostojić, Noa G. Holtzman, Dana A. Schaar, Edward W. Cowen
Publikováno v:
Transplant Cell Ther
Subsequent cancer (SC) is a significant cause of morbidity and mortality in long-term survivors after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Chronic graft-versus-host disease (cGVHD) and treatment-related immunosuppression ha
Autor:
Hemant S. Murthy, Kwang Woo Ahn, Noel Estrada-Merly, Hassan B. Alkhateeb, Susan Bal, Mohamed A. Kharfan-Dabaja, Bhagirathbhai Dholaria, Francine Foss, Lohith Gowda, Deepa Jagadeesh, Craig Sauter, Muhammad Bilal Abid, Mahmoud Aljurf, Farrukh T. Awan, Ulrike Bacher, Sherif M. Badawy, Minoo Battiwalla, Chris Bredeson, Jan Cerny, Saurabh Chhabra, Abhinav Deol, Miguel Angel Diaz, Nosha Farhadfar, César Freytes, James Gajewski, Manish J. Gandhi, Siddhartha Ganguly, Michael R. Grunwald, Joerg Halter, Shahrukh Hashmi, Gerhard C. Hildebrandt, Yoshihiro Inamoto, Antonio Martin Jimenez-Jimenez, Matt Kalaycio, Rammurti Kamble, Maxwell M. Krem, Hillard M. Lazarus, Aleksandr Lazaryan, Joseph Maakaron, Pashna N. Munshi, Reinhold Munker, Aziz Nazha, Taiga Nishihori, Olalekan O. Oluwole, Guillermo Ortí, Dorothy C. Pan, Sagar S. Patel, Attaphol Pawarode, David Rizzieri, Nakhle S. Saba, Bipin Savani, Sachiko Seo, Celalettin Ustun, Marjolein van der Poel, Leo F. Verdonck, John L. Wagner, Baldeep Wirk, Betul Oran, Ryotaro Nakamura, Bart Scott, Wael Saber
Publikováno v:
Murthy, Hemant S; Ahn, Kwang Woo; Estrada-Merly, Noel; Alkhateeb, Hassan B; Bal, Susan; Kharfan-Dabaja, Mohamed A; Dholaria, Bhagirathbhai; Foss, Francine; Gowda, Lohith; Jagadeesh, Deepa; Sauter, Craig; Abid, Muhammad Bilal; Aljurf, Mahmoud; Awan, Farrukh T; Bacher, Ulrike; Badawy, Sherif M; Battiwalla, Minoo; Bredeson, Chris; Cerny, Jan; Chhabra, Saurabh; ... (2022). Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplantation and cellular therapy, 28(4), 187.e1-187.e10. Elsevier 10.1016/j.jtct.2022.01.017
Transplant Cell Ther
Transplantation and Cellular Therapy, 28(4), 187.e1-187.e10. Elsevier
Transplant Cell Ther
Transplantation and Cellular Therapy, 28(4), 187.e1-187.e10. Elsevier
T cell prolymphocytic leukemia (T-PLL) is a rare, aggressive malignancy with limited treatment options and poor long-term survival. Previous studies of allogeneic hematopoietic cell transplantation (alloHCT) for T-PLL are limited by small numbers, an
Autor:
Alan P Skarbnik, Paul Fields, Pashna N. Munshi, Michele L. Donato, Scott D. Rowley, Joshua Zenreich, Tatyana Feldman, Andrew L. Pecora, David H. Vesole, Lori A. Leslie, Dante B. Descalzi-Montoya, Andre Goy, Noa Biran, Themba Nyirenda, Rena Feinman, Robert Korngold
Publikováno v:
Transplantation and cellular therapy. 27(5)
Autologous hematopoietic stem cell transplantation (ASCT) is a standard-of-care treatment for many hematologic malignancies. Progression of disease after ASCT is the primary cause of treatment failure. In this Phase Ib trial, we studied the safety an